Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea

Clinical trial NCT05409300 · UNKNOWN

Trial details

NCT number: NCT05409300
Sponsor: ANRS, Emerging Infectious Diseases
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Vaccine Adverse Reaction Sars-CoV-2 Infection Healthy Volunteer

Start date: 2022-04-25
Primary completion: 2023-08-03
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.